Defining the scope of evidence-based practice for low-molecular-weight heparin therapy in high-risk patients with unstable angina and non-st-elevation myocardial infarction
1999 ◽
Vol 20
(21)
◽
pp. 1553-1562
◽
2020 ◽
Vol 13
(7)
◽
pp. 3151
2008 ◽
Vol 26
(2)
◽
pp. 85-90
◽
2005 ◽
Vol 112
(25)
◽
pp. 3846-3854
◽
2005 ◽
Vol 112
(25)
◽
pp. 3855-3867
◽
Keyword(s):